Join the limbic and a panel of experts to discuss the highly anticipated ‘game changer’ trials unveiled at the ASCO virtual meeting this week.
Chaired by Professor Eva Segelov, Director of Oncology at Monash Health, an expert from each cancer sub-specialty will present the key papers in their field and provide commentary on how the findings will have implications for the way Australian oncologists practice medicine.
Viewers will have the opportunity to ask the panel questions during the live event.
7:00PM – PATIENT CARE
Doctor Christoper Jackson. Consultant Medical Oncologist at Mercy Cancer Care, Dunedin. Clinical Leader for Oncology Research, Dunedin Hospital. Co-founder of Mercy Cancer Care. Medical Director, Cancer Society of New Zealand.
7:20PM – MELANOMA
Professor Georgina Long. Co-Medical Director of Melanoma Institute Australia (MIA)
Chair, Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, The University of Sydney.
7:40PM – BREAST CANCER
Doctor Belinda Yeo. Medical Oncologist, ONJ Centre, Austin Health, Melbourne. Clinician Scientist, Olivia Newton-John Cancer Research Institute. Honorary Associate, School of Cancer Medicine, La Trobe University. Co-lead of the VCCC Research and Education of the Breast Tumour Stream.
8:00PM – LUNG CANCER
Professor Michael Millward. Foundation Chair of Clinical Cancer Research, University of Western Australia. Consultant Medical Oncologist, Sir Charles Gairdner Hospital and Linear Clinical Research, Perth.
8:20PM – GI CANCERS
Professor Chris Karapetis. Head, Medical Oncology, Flinders Medical Centre. Network Director, Cancer Services, Southern Area LHN, Adelaide. Director, Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders Centre for Innovation in Cancer.
8:40PM – GU CANCERS
A/Professor Jeremy Shapiro. Gastro-intestinal and Genito-urinary Oncologist, Cabrini Hospital, Melbourne. Associate Professor of Medicine, Monash University. Lead researcher, Australia Gasto-Intestinal Tumour Group.
This webinar was developed independently by the limbic. Thank you to Merck Healthcare Pty Ltd and Bristol Myers Squibb Australia Pty Ltd for providing the financial support that made it possible.